A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer

Oza, Amit M.; Estevez-Diz, Maria; Grischke, Eva-Maria; Hall, Marcia; Marme, Frederik; Provencher, Diane; Uyar, Denise; Weberpals, Johanne I.; Wenham, Robert M.; Laing, Naomi; Tracy, Michael; Freshwater, Tomoko; Lee, Mark A.; Liu, Ji; Qiu, Jingjun; Rose, Shelonitda; Rubin, Eric H.; Moore, Kathleen

A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer

Autor(en):

Oza, Amit M.; Estevez-Diz, Maria; Grischke, Eva-Maria; Hall, Marcia; Marme, Frederik; Provencher, Diane; Uyar, Denise; Weberpals, Johanne I.; Wenham, Robert M.; Laing, Naomi; Tracy, Michael; Freshwater, Tomoko; Lee, Mark A.; Liu, Ji; Qiu, Jingjun; Rose, Shelonitda; Rubin, Eric H.; Moore, Kathleen

Tübinger Autor(en):

Grischke, Eva-Maria

Erschienen in:

Clinical Cancer Research (2020), Bd. 26, H. 18, S. 4767-4776

Verlagsangabe:

Amer Assoc Cancer Research

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1158/1078-0432.CCR-20-0219

ISSN:

1557-3265